MANNATECH INC

MTEX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $108.0M $117.9M $132.0M $137.2M $159.8M $151.4M $157.7M $173.6M
Cost of Revenue $27.1M $26.4M $29.1M $33.1M $34.1M $35.5M $31.6M $34.5M
Gross Profit $81.0M $91.5M $102.9M $104.1M $125.6M $115.9M $126.2M $139.1M
Gross Margin 74.9% 77.6% 78.0% 75.9% 78.6% 76.5% 80.0% 80.1%
Operating Expenses
Research & Development $800.0K $700.0K $800.0K $1.0M $1.2M $800.0K $1.1M $1.0M
SG&A Expense $39.7M $41.7M $50.2M $47.4M $29.4M $27.8M $30.8M $34.2M
Operating Income $-426.0K $1.4M $-964.0K $-405.0K $9.0M $4.5M $6.4M $-90.0K
Operating Margin -0.4% 1.2% -0.7% -0.3% 5.7% 3.0% 4.1% -0.1%
Interest Expense
Pretax Income $-2.9M $3.7M $-1.1M $-479.0K $8.9M $5.7M $5.7M $489.0K
Income Tax Expense $12.3M $1.3M $1.1M $4.0M $-950.0K $-536.0K $2.4M $4.4M
Net Income $-15.2M $2.5M $-2.2M $-4.5M $9.8M $6.3M $3.3M $-3.9M
Net Margin -14.1% 2.1% -1.7% -3.3% 6.2% 4.1% 2.1% -2.2%
EPS (Basic) $-8.00 $1.32 $-1.20 $-2.35 $4.95 $2.80 $1.38 $-1.53
EPS (Diluted) $-8.00 $1.32 $-1.20 $-2.35 $4.71 $2.77 $1.35 $-1.53
Shares Outstanding (Basic) 1.9M 1.9M 1.9M 1.9M 2.0M 2.2M 2.4M 2.5M
Shares Outstanding (Diluted) 1.9M 1.9M 1.9M 1.9M 2.1M 2.3M 2.4M 2.5M
Dividends Per Share $0.20
← Newer Page 1 of 3 Older →